Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Formula corrected maximal standardized uptake value in FDG-PET for partial volume effect and motion artifact is not a prognostic factor in stage I non-small cell lung cancer treated with stereotactic body radiotherapy.

Yamamoto T, Kadoya N, Shirata Y, Kaneta T, Koto M, Umezawa R, Ishikawa Y, Kubozono M, Sugawara T, Matsushita H, Abe K, Takeda K, Jingu K.

Ann Nucl Med. 2015 Jun 4. [Epub ahead of print]

PMID:
26040413
2.

Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy.

Yamamoto T, Kadoya N, Shirata Y, Koto M, Sato K, Matsushita H, Sugawara T, Umezawa R, Kubozono M, Ishikawa Y, Kozumi M, Takahashi N, Ito K, Katagiri Y, Takeda K, Jingu K.

Radiat Oncol. 2015 Feb 7;10:35. doi: 10.1186/s13014-015-0343-6.

3.

Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors.

Yamamoto T, Jingu K, Shirata Y, Koto M, Matsushita H, Sugawara T, Kubozono M, Umezawa R, Abe K, Kadoya N, Ishikawa Y, Kozumi M, Takahashi N, Takeda K, Takai Y.

BMC Cancer. 2014 Jun 23;14:464. doi: 10.1186/1471-2407-14-464.

4.

Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study.

Jingu K, Matsushita H, Takeda K, Umezawa R, Takahashi C, Sugawara T, Kubozono M, Abe K, Tanabe T, Shirata Y, Yamamoto T, Ishikawa Y, Nemoto K.

BMC Cancer. 2012 Nov 22;12:542. doi: 10.1186/1471-2407-12-542.

5.

Prognostic factors for local control of stage I non-small cell lung cancer in stereotactic radiotherapy: a retrospective analysis.

Shirata Y, Jingu K, Koto M, Kubozono M, Takeda K, Sugawara T, Kadoya N, Matsushita H.

Radiat Oncol. 2012 Oct 31;7:182. doi: 10.1186/1748-717X-7-182.

6.

Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan.

Takeda K, Takai Y, Narazaki K, Mitsuya M, Umezawa R, Kadoya N, Fujita Y, Sugawara T, Kubozono M, Shimizu E, Abe K, Shirata Y, Ishikawa Y, Yamamoto T, Kozumi M, Dobashi S, Matsushita H, Chida K, Ishidoya S, Arai Y, Jingu K, Yamada S.

Radiat Oncol. 2012 Jul 6;7:105. doi: 10.1186/1748-717X-7-105.

7.

Experimental realization of a spin-1/2 triangular-lattice Heisenberg antiferromagnet.

Shirata Y, Tanaka H, Matsuo A, Kindo K.

Phys Rev Lett. 2012 Feb 3;108(5):057205. Epub 2012 Jan 31.

PMID:
22400958
8.

Adult human parvovirus-B19 infection presenting with hearing difficulty and dizziness.

Nara M, Shirata Y, Kikuchi T, Hongo M.

Tohoku J Exp Med. 2011;224(1):57-9.

9.
10.

[Continuous hepatic arterial infusion of 5-fluorouracil with leucovorin for unresectable liver metastases from colorectal cancer].

Yamamura T, Ozasa T, Suda T, Asakura T, Adachi Y, Isogai A, Shirata Y, Kurisu S, Taira Y.

Gan To Kagaku Ryoho. 2000 Oct;27(12):1897-9. Japanese.

PMID:
11086440
11.
12.

[Clinical use of absorbable polyglycolic acid suture in Blalock-Taussig's operation].

Irisawa T, Kobayashi M, Nakamura C, Katagiri M, Sato T, Imai K, Watanabe T, Ishihara R, Sato Y, Nishimura K, Orita H, Shirata Y, Isoda N, Hoshi E, Washio M, Ishihara T, Sato T.

Kyobu Geka. 1983 Feb;36(2):110-4. Japanese. No abstract available.

PMID:
6341661
13.

[Angiographic findings on the vibration disease (author's transl)].

Oikawa M, Kakuhara N, Asanuma T, Yanagisawa T, Tarusawa S, Hakoishi K, Shirata Y, Watanabe Y.

Rinsho Hoshasen. 1978 May;23(5):563-7. Japanese. No abstract available.

PMID:
660940
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk